RegenLab USA, Inc. (RGNA)
RegenLab USA will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

RegenLab USA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec '25 Dec '24
Debt / Equity Ratio
-4.11-4.33-4.25
Debt / EBITDA Ratio
11.27201.985.02
Debt / FCF Ratio
14.30-19.6925.93
Net Debt / Equity Ratio
-3.61-4.13-4.13
Net Debt / EBITDA Ratio
9.91193.024.88
Net Debt / FCF Ratio
12.57-18.8225.18
Quick Ratio
0.380.290.31
Interest Coverage
0.66-3.114.47
Return on Equity (ROE)
11.67%12.90%-29.65%
Return on Assets (ROA)
--2.34%5.21%
Return on Invested Capital (ROIC)
-2.82%11.34%
Return on Capital Employed (ROCE)
-7.02%-3.01%14.31%